VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.
AffiliationCancer Research UK and University of Manchester Department of Medical Oncology, Christie Hospital National Health Service Trust, Wilmslow Road, Manchester M20 4BX, United Kindgom. Christopher.Robinson@manchester.ac.uk
MetadataShow full item record
AbstractThe vascular endothelial growth factor (VEGF) family of proteins controls the formation and growth of blood vessels. The most potent and widely expressed isoform, VEGF165, is secreted as a disulfide-linked homodimer with two identical heparin-binding sites. Interactions with heparan sulfate (HS) regulate the diffusion, half-life, and affinity of VEGF165 for its signaling receptors. We have determined a number of key HS structural features that mediate the specific binding of the VEGF165 dimer. Carboxylate groups and 2-O-, 6-O-, and N-sulfation of HS contributed to the strength of the VEGF165 interaction; however, 6-O-sulfates appeared to be particularly important. Cleavage of HS by heparinase, heparitinase, or heparanase severely reduced VEGF165 binding. In contrast, K5 lyase-cleaved HS retained significant VEGF165 affinity, suggesting that binding sites for the growth factor are present within extended stretches of sulfation. Binding studies and molecular modeling demonstrated that an oligosaccharide 6 or 7 residues long was sufficient to fully occupy the heparin-binding site of a VEGF165 monomer. The data presented are consistent with a model whereby the two heparin-binding sites of the VEGF165 dimer interact simultaneously with highly sulfated S-domain regions of the HS chain that can be linked through a stretch of transition sequence.
CitationVEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. 2006, 281 (3):1731-40 J. Biol. Chem.
JournalThe Journal of Biological Chemistry
- Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
- Authors: Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT
- Issue date: 1994 Apr 15
- Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
- Authors: Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K
- Issue date: 2004 Mar 26
- A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.
- Authors: Murphy KJ, Merry CL, Lyon M, Thompson JE, Roberts IS, Gallagher JT
- Issue date: 2004 Jun 25
- Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins.
- Authors: Freeman C, Liu L, Banwell MG, Brown KJ, Bezos A, Ferro V, Parish CR
- Issue date: 2005 Mar 11
- Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins.
- Authors: Ashikari-Hada S, Habuchi H, Kariya Y, Kimata K
- Issue date: 2005 Sep 9